Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lambert M, Conus P, Lubman DI, Wade D, Yuen H, Moritz S, Naber D, McGorry PD, Schimmelmann BG (2005) The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 112(2):141–148. https://doi.org/10.1111/j.1600-0447.2005.00554.x
Wade D, Harrigan S, McGorry PD, Burgess PM, Whelan G (2007) Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J Clin Psychiatry 68(5):767–774
Cantor-Graae E, Nordstrom LG, McNeil TF (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 48(1):69–82
Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2009) Prevalence of alcohol use disorders in schizophrenia—a systematic review and meta-analysis. Acta Psychiatr Scand 120(2):85–96. https://doi.org/10.1111/j.1600-0447.2009.01385.x
Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2010) Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36(6):1115–1130. https://doi.org/10.1093/schbul/sbp031
Sara GE, Large MM, Matheson SL, Burgess PM, Malhi GS, Whiteford HA, Hall WD (2015) Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. Aust N Zeal J Psychiatry 49(2):106–117. https://doi.org/10.1177/0004867414561526
Ayano G (2019) Co-occurring medical and substance use disorders in patients with schizophrenia: a systematic review. Int J Ment Health 48(1):62–76. https://doi.org/10.1080/00207411.2019.1581047
Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: systematic review and meta-analysis. Drug Alcohol Depend 191:234–258. https://doi.org/10.1016/j.drugalcdep.2018.07.011
Gut-Fayand A, Dervaux A, Olie JP, Loo H, Poirier MF, Krebs MO (2001) Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 102(1):65–72
Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E (2000) The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand 101(6):452–456
Cuffel BJ, Heithoff KA, Lawson W (1993) Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 44(3):247–251
Jimenez-Castro L, Hare E, Medina R, Raventos H, Nicolini H, Mendoza R, Ontiveros A, Jerez A, Munoz R, Dassori A, Escamilla M (2010) Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry. Schizophr Res 120(1–3):87–94. https://doi.org/10.1016/j.schres.2010.02.1053
Kerfoot KE, Rosenheck RA, Petrakis IL, Swartz MS, Keefe RS, McEvoy JP, Stroup TS (2011) Substance use and schizophrenia: adverse correlates in the CATIE study sample. Schizophr Res 132(2–3):177–182. https://doi.org/10.1016/j.schres.2011.07.032
Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 67(2–3):157–166. https://doi.org/10.1016/s0920-9964(02)00523-6
Rush B, Koegl CJ (2008) Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatry 53(12):810–821. https://doi.org/10.1177/070674370805301207
Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM (2003) Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res 61(1):89–95
Scheller-Gilkey G, Moynes K, Cooper I, Kant C, Miller AH (2004) Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. Schizophr Res 69(2–3):167–174
Seedat F, Roos JL, Pretorius HW, Karayiorgou M, Nel B (2007) Prevalence and clinical characteristics of obsessive-compulsive disorder and obsessive compulsive symptoms in Afrikaner schizophrenia and schizoaffective disorder patients. Afr J Psychiatry (Johannesbg) 10(4):219–224
Shoval G, Zalsman G, Apter A, Diller R, Sher L, Weizman A (2007) A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use. Compr Psychiatry 48(1):1–7. https://doi.org/10.1016/j.comppsych.2006.05.002
Carra G, Crocamo C, Borrelli P, Popa I, Ornaghi A, Montomoli C, Clerici M (2015) Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the “Psychiatric and Addictive Dual Disorder in Italy (PADDI)” Study. Compr Psychiatry 58:152–159. https://doi.org/10.1016/j.comppsych.2014.11.021
Compton MT, Simmons CM, Weiss PS, West JC (2011) Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity. Am J Addict 20(6):563–567. https://doi.org/10.1111/j.1521-0391.2011.00184.x
Compton MT, Weiss PS, West JC, Kaslow NJ (2005) The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Soc Psychiatry Psychiatr Epidemiol 40(12):939–946. https://doi.org/10.1007/s00127-005-0964-4
Helseth V, Lykke-Enger T, Johnsen J, Waal H (2009) Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry 63(1):72–77. https://doi.org/10.1080/08039480802450439
Paruk S, Burns JK, Caplan R (2013) Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. J Child Adolesc Ment Health 25(1):61–68. https://doi.org/10.2989/17280583.2013.767264
Taukoor B, Paruk S, Karim E, Burns JK (2017) Substance use in adolescents with mental illness in Durban, South Africa. J Child Adolesc Ment Health 29(1):51–61. https://doi.org/10.2989/17280583.2017.1318395
Vos PJ, Cloete KJ, le Roux A, Kidd M, Jordaan GP (2010) A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context. Afr J Psychiatry 13(5):390–394
Weich L, Pienaar W (2009) Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Afr J Psychiatry 12(3):213–217
First M, RL S, M G, JBW W (1994) Structured clinical interview for DSM-IV Axis I disorders-Patient Edition (SCID-I-P, version 2)
https://www.scid4.org Structured Clinical Interview for DSM-IV. Biometrics Research Department. Accessed 15 Jan 2018
Campbell MM, Susser E, Mall S, Mqulwana SG, Mndini MM, Ntola OA, Nagdee M, Zingela Z, Van Wyk S, Stein DJ (2017) Using iterative learning to improve understanding during the informed consent process in a South African psychiatric genomics study. PLoS ONE 12(11):e0188466. https://doi.org/10.1371/journal.pone.0188466
Mall S, Platt JM, Temmingh H, Musenge E, Campbell M, Susser E, Stein DJ (2019) The relationship between childhood trauma and schizophrenia in the Genomics of Schizophrenia in the Xhosa people (SAX) study in South Africa. Psychol Med. https://doi.org/10.1017/s0033291719001703
Koen L, Niehaus DJ, Wright G, Warnich L, De Jong G, Emsley RA, Mall S (2012) Chromosome 22q11 in a Xhosa schizophrenia population. S Afr Med J 102(3 Pt 1):165–166. https://doi.org/10.7196/samj.5326
South African Institute of Race Relations. South African Survey Online (2003) www.irr.org.za. Accessed 15 Jan 2014
Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33(6):766–771
Sartorius N, Janca A (1996) Psychiatric assessment instruments developed by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol 31(2):55–69
Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC (2007) A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry 64(8):966–974. https://doi.org/10.1001/archpsyc.64.8.966
StataCorp (2013) Stata statistical software: release 13. StataCorp LP, College Station
Thungana Y, Zingela Z, van Wyk S (2019) First-episode psychosis and substance use in Nelson Mandela Bay: findings from an acute mental health unit. S Afr J Psychiatry 25:1372. https://doi.org/10.4102/sajpsychiatry.v25i0.1372
Herman AA, Stein DJ, Seedat S, Heeringa SG, Moomal H, Williams DR (2009) The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J 99(5 Pt 2):339–344
Gregg L, Barrowclough C, Haddock G (2007) Reasons for increased substance use in psychosis. Clin Psychol Rev 27(4):494–510. https://doi.org/10.1016/j.cpr.2006.09.004
Gage SH, Hickman M, Zammit S (2016) Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiat 79(7):549–556. https://doi.org/10.1016/j.biopsych.2015.08.001
Mané A, Fernández-Expósito M, Bergé D, Gómez-Pérez L, Sabaté A, Toll A, Diaz L, Diez-Aja C, Perez V (2015) Relationship between cannabis and psychosis: reasons for use and associated clinical variables. Psychiatry Res 229(1–2):70–74. https://doi.org/10.1016/j.psychres.2015.07.070
Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC (2014) Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Zeal J Psychiatry 48(11):1036–1047. https://doi.org/10.1177/0004867414533838
Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 194(3):164–172. https://doi.org/10.1097/01.nmd.0000202575.79453.6e
Pluddemann A, Dada S, Parry CD, Kader R, Parker JS, Temmingh H, van Heerden S, de Clercq C, Lewis I (2013) Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa. Afr J Psychiatry (Johannesbg) 16(1):45–49
Hobkirk AL, Watt MH, Myers B, Skinner D, Meade CS (2016) A qualitative study of methamphetamine initiation in Cape Town, South Africa. Int J Drug Pol 30:99–106. https://doi.org/10.1016/j.drugpo.2015.10.006
Morgan N, Mall S (2019) Pathways between urbanization and harmful substance use. Curr Opin Psychiatry 32(3):218–223. https://doi.org/10.1097/yco.0000000000000488
Saban A, Flisher AJ, Grimsrud A, Morojele N, London L, Williams DR, Stein DJ (2014) The association between substance use and common mental disorders in young adults: results from the South African Stress and Health (SASH) Survey. Pan Afr Med J 17(Suppl 1):11. https://doi.org/10.11694/pamj.supp.2014.17.1.3328
O'Hare T, Sherrer MV, Shen C (2006) Subjective distress from stressful events and high-risk behaviors as predictors of PTSD symptom severity in clients with severe mental illness. J Trauma Stress 19(3):375–386. https://doi.org/10.1002/jts.20131
O'Hare T, Sherrer M (2011) Drinking motives as mediators between PTSD symptom severity and alcohol consumption in persons with severe mental illnesses. Addict Behav 36(5):465–469. https://doi.org/10.1016/j.addbeh.2011.01.006
Andrade C (2016) Cannabis and neuropsychiatry, 2: the longitudinal risk of psychosis as an adverse outcome. J Clin Psychiatry 77(6):e739–742. https://doi.org/10.4088/JCP.16f10918
Hermens DF, Lubman DI, Ward PB, Naismith SL, Hickie IB (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(4 Suppl):S22–25